Tsuchimoto Kim R

DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Aug 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$456K
Net Open-Market Flow
-$456K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2026Sell(S)485$108.83$53K11K
Aug 26, 2026Sell(S)615$109.56$67K10K
Aug 26, 2026Sell(S)700$110.65$77K10K
Aug 26, 2026Sell(S)1K$111.84$123K9K
Aug 26, 2026Sell(S)602$112.93$68K8K
Aug 26, 2026Sell(S)590$113.84$67K7K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-029116) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about MNPR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-26-029116"
Ask your agent
Use Arkolith to summarize insider buying and selling at Monopar Therapeutics
over the last 90 days and cite the filings.